Vaginal Mucosa – A Promising Site for Drug Therapy

References (55)

1. 1 Percutaneous Absorption. On the Relevance of in Vitro Data [DOI]
2. 2 Drug Delivery via the Mucous Membranes of the Oral Cavity [DOI]
3. 3 Emerging Role of Lactobacilli in the Control and Maintenance of the Vaginal Bacterial Microflora [DOI]
4. 4 Global prevalence and incidence estimates of selected curable STDs.
5. 5 Origins of vaginal acidity: high d/l lactate ratio is consistent with bacteria being the primary source [DOI]
6. 6 The vagina as a route for systemic drug delivery [DOI]
7. 7 The use of mucoadhesive polymers in vaginal delivery [DOI]
8. 8 Ocular drug delivery [DOI]
9. 9 Why consider vaginal drug administration? [DOI]
10. 10 Bioadhesion [DOI]
11. 11 Gels as vaginal drug delivery systems [DOI]
12. 12 The scope and potential of vaginal drug delivery [DOI]
13. 13 Factors and strategies for improving buccal absorption of peptides [DOI]
14. 14 Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide [DOI]
15. 15 The Active Ion Transport through the Isolated Frog Skin in the Light of Tracer Studies [DOI]
16. 16 Vaginal microbial diversity among postmenopausal women with and without hormone replacement therapy [DOI]
17. 17 (D) Routes of delivery: Case studies [DOI]
18. 18 Drug Delivery by the Intravaginal Route [DOI]
19. 19 Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM) [DOI]
20. 20 Experience with a novel vaginal progesterone preparation in a donor oocyte program [DOI]
21. 21 Vaginal and reproductive system treatments using a bioadhesive polymer [DOI]
22. 22 Human cervical mucus: Research update [DOI]
23. 23 Spectrum of Lactobacillus species present in healthy vagina of Indian women.
24. 24 Hydrogel delivery systems for vaginal and oral applications [DOI]
25. 25 Vaginal Microbial Flora: Composition and Influences of Host Physiology [DOI]
26. 26 Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations [DOI]
27. 27 Vaginal colonization by bacteria and yeast [DOI]
28. 28 Validation protocol of an automated in-line flow-through diffusion equipment for in vitro permeation studies [DOI]
29. 29 Intravaginal drug delivery [DOI]
30. 30 Is Mycoplasma hominis a vaginal pathogen? [DOI]
31. 31 Ovulation induced by mucosa vaginal absorption of buserelin and triptorelin in rabbit [DOI]
32. 32 Effects of Physiological Fluids on Physical-Chemical Characteristics and Activity of Topical Vaginal Microbicide Products [DOI]
33. 33 Vaginal drug delivery systems: A Review of Current Status [DOI]
34. 34 Formulation and In Vitro Evaluation of In Situ Gels Containing Secnidazole for Vaginitis [DOI]
35. 35 Ketoprofen Suppository Dosage Forms: In Vitro Release and in Vivo Absorption Studies in Rabbits [DOI]
36. 36 Vaginal ring delivery of hormone replacement therapy ? a review [DOI]
37. 37 Contraceptive Vaginal Rings [DOI]
38. 38 Influence of non-ionic surfactants on permeation of hydrocortisone, dexamethasone, testosterone and progesterone across cellulose acetate membrane [DOI]
39. 39 Phase I Clinical Trial of Repeat Dose Terameprocol Vaginal Ointment in Healthy Female Volunteers [DOI]
40. 40 Development and Evaluation of a Suppository Formulation Containing Lactobacillus and Its Application in Vaginal Diseases [DOI]
41. 41 Systems Approach to Vaginal Delivery of Drugs IV: Methodology for Determination of Membrane Surface pH [DOI]
42. 42 Drug treatment of common STDs: Part II. Vaginal infections, pelvic inflammatory disease and genital warts.
43. 43 Design and Development of an in Vitro Assay for Evaluation of Solid Vaginal Dosage Forms [DOI]
44. 44 The absorption and uptake of recombinant human follicle-stimulating hormone through vaginal subcutaneous injections - a pharmacokinetic study [DOI]
45. 45 The use of over-the-counter antifungal vaginitis preparations by college students.
46. 46 Vaginal pH effects caused by OCs and various copper and inert IUDs.
47. 47 Vaginitis and vaginal preparations
48. 48 Diffusion barriers in the vaginal epithelium during the estrous cycle in guinea pigs [DOI]
49. 49 Vaginal Drug Delivery [DOI]
50. 50 THE ROLE OF SURFACTANT IN, AND A COMPARISON OF, THE PERMEABILITY OF PORCINE AND HUMAN EPITHELIA TO VARIOUS CHEMICAL COMPOUNDS
51. 51 Physiology and ecology of the vagina.
52. 52 Development and characterization of bioadhesive gel of microencapsulated metronidazole for vaginal use.
53. 53 Proposed Design of a Dissolution Apparatus for Vaginal Formulations Containing Probiotics [DOI]
54. 54 A morphologist's approach to the vagina.
55. 55 Studies on vaginal bioadhesive tablets of acyclovir.

Cited by 19

Showing 17 of 19 known citations — external sources report more than can currently be individually listed.

Related research

• P. pentosaceus Administration Attenuates the Severity of Dextran Sulfate Sodium-Induced Colitis and Improve the Intestinal Permeability — shares topic coverage
• Assessing Groundwater Vulnerability to the Activities of Artisanal Refining in Bolo and Environs, Ogu/Bolo Local Government Area of Rivers State; Nigeria — shares topic coverage
• Effects of Leaking Septic Tanks on Underground Water Quality in Owerri Municipal, Imo State, Nigeria — shares topic coverage
• Determination of Some Petrophysical Properties of Reservoir Rocks in the Niger Delta — shares topic coverage
• Analysis of Comfort Properties of Mulberry Silk and Viscose Blended Knitted Fabrics for Suitability in Temperate Regions — shares topic coverage